Revolutionizing Brain Cancer Treatment: Key Target Discovered by Our Research Team
Read MoreNEW RESEARCH REVEALS LINK BETWEEN SPINAL MUSCULAR ATROPHY (SMA) AND LIVER DAMAGE
INTERNATIONAL RESEARCH TEAM UNVEILS IMPACT OF EAST ASIAN GENE VARIANT ON TYPE 2 DIABETES RISK
The surprising interplay between metabolism and mind
Scientists Discover How Deadly Skin Cancer Evades The Human Immune System
Congratulations to Associate Professor Su Xinyi on her official appointment as Executive Director of IMCB, effective from March 1, 2024.
Nurturing the next generation of scientific talents
Overcoming barriers in brain cancer
Groundbreaking technology sheds light on the mysteries of RNA modifications
IMCB warmly welcomes new Acting Executive Director, Dr Su Xinyi
IMCB spin-off Albatroz takes flight
IMCB reseacher awarded the National Research Foundation Competitive Research Programme (CRP) funding
Advancing retinal cell therapy: New insights into transplanted retinal cells could treat degenerative vision in elderly
IMCB researcher awarded the NRF class of 2023 fellowship
Unlocking a key to kidney cancer: New research advances understanding of tumour growth
New discovery in T-Cell research could lead to improved treatment of solid tumours
Singapore study discovers novel therapeutic target to advance the treatment of diabetic eye diseases
Congratulations to IMCB’s latest PhD graduate – Hwee Hui LAU
President's Science and Technology Awards(PSTA) 2022